MedPath

The role of the norepinephrine system in emotion, vigilance and error processing.

Completed
Conditions
focus op het gezonde brein
niet van toepassing
Registration Number
NL-OMON32686
Lead Sponsor
niversiteit Leiden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Adult subjects between the ages 18 and 30 with no history of neurological disorder/disease and normal blood pressure and heart rate will be included in this study. All participants will be right-handed native Dutch speakers.

Exclusion Criteria

Low blood pressure, bradycardia, cardiac arrhythmia, severe pulmonary conditions, head trauma, learning disabilities, and history of neurological or psychiatric illness and/or use of (psychotropic) medication. Further, subjects with Dutch as a second language and left-handed individuals will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter is the EEG measurement. The endpoint is the effect of<br /><br>propranolol on the EEG signal. We hypothesize that propranolol will decrease<br /><br>the amplitude of the different components of the EEG signal that we<br /><br>investigate.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameter is subsequent memory (% correctly recognized<br /><br>stimuli after the 2 week interval). The endpoint is the effect of propranolol<br /><br>on subsequent memory. We hypothesize that subsequent memory will be better for<br /><br>emotional than for neutral stimuli (higher % correctly recognized stimuli after<br /><br>the 2 week interval) and that this difference will decrease because of<br /><br>propranolol.</p><br>
© Copyright 2025. All Rights Reserved by MedPath